- Email: [email protected]
Tetra Pak adds to filtration portfolio with US acquisition
NEWS/EXCHANGE RATES
Tetra Pak adds to filtration portfolio with US acquisition
P
ackaging giant Tetra Pak has acquired Minneapolis, USA-based Filtration Engineering Company Inc, a manufacturer of membrane filtration technology for the dairy and cheese industries. Established in 1982, Filtration Engineering specialises in the design, construction and commissioning of membrane filtration systems used in milk, whey and specialised waste treatment systems. The privately-held company employs 39 people. The acquisition brings together Filtration Engineering’s expertise in spiral membrane technology and Tetra Pak’s existing ceramic membrane systems portfolio. The two companies have worked together on a number of projects in the US over the last 10 years. “The acquisition of Filtration Engineering strengthens our portfolio of products, solutions and services for dairy and cheese applications as well as provides us with additional knowledge and competence,” said Tim High, executive vice president of Processing Systems at Tetra Pak. “Adding Filtration Engineering’s technical expertise in membrane filtration and its US market leadership to our expertise in ceramic filtration and global market presence is a winning combination for Filtration Engineering, Tetra Pak and our customers around the world.”
Filtration Engineering, which will remain at its current location in Champlin, Minnesota, will become a unit of Tetra Pak Cheese and Powder Systems Inc. The existing Filtration Engineering sales channels outside the US will be maintained in a number of markets. The Filtration Engineering business will have further global coverage through Tetra Pak’s own marketing operations. For further information, visit www.tetrapak.com and www.filtrationeng.com
Toray extends Californian base
T
oray Membrane USA Inc (TMUS) has bought a building next to its existing manufacturing facility in Poway, California for sales and storage. The 15 000 sq ft building will be used as a finished goods warehouse for membrane bioreactor (MBR), hollow fine fibre and dairy/food/beverage spiral reverse osmosis (RO) and ultrafiltration (UF) membrane elements. The new building also includes offices for the TMUS sales, marketing, customer service, applications engineering and technical service departments. TMUS now owns all three buildings on the Californian campus.
For further information, visit www.toraywater.com
Exchange Rates against the US Dollar Date: 24.1.2013 Country Australia
Rate A$0.96
Country Netherlands
Austria
E0.75
Norway
Belgium
E0.75
Philippines
C$1.00
Singapore
Canada
Rate E0.75 NOK5.52 Peso40.71 S$1.23
China
CNY6.23
South Africa
R9.00
Denmark
DKK5.55
South Korea
KWn1074.79
Finland
E0.75
Spain
France
E0.75
Sweden
SEK6.47
Germany
E0.75
Switzerland
CHF0.93
Taiwan
T$29.17
Thailand
Bt29.89
India Italy
Rs53.76 E0.75
Japan
¥89.61
UK
Malaysia
Rt3.05
USA
16
Filtration Industry Analyst
E0.75
£0.63
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Fax: +44 (0) 1865 843973 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Publisher: David Hopwood Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Prices: 1291 for all European countries & Iran US$1448 for all countries except Europe and Japan ¥171 700 for Japan (Prices valid until 31 December 2013) To subscribe send payment to the address above. Tel: +44 (0)1865 843687 or via www.filtrationindustryanalyst.com Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 12976
US$1.00
January 2013
Tetra Pak adds to filtration portfolio with US acquisition
P
ackaging giant Tetra Pak has acquired Minneapolis, USA-based Filtration Engineering Company Inc, a manufacturer of membrane filtration technology for the dairy and cheese industries. Established in 1982, Filtration Engineering specialises in the design, construction and commissioning of membrane filtration systems used in milk, whey and specialised waste treatment systems. The privately-held company employs 39 people. The acquisition brings together Filtration Engineering’s expertise in spiral membrane technology and Tetra Pak’s existing ceramic membrane systems portfolio. The two companies have worked together on a number of projects in the US over the last 10 years. “The acquisition of Filtration Engineering strengthens our portfolio of products, solutions and services for dairy and cheese applications as well as provides us with additional knowledge and competence,” said Tim High, executive vice president of Processing Systems at Tetra Pak. “Adding Filtration Engineering’s technical expertise in membrane filtration and its US market leadership to our expertise in ceramic filtration and global market presence is a winning combination for Filtration Engineering, Tetra Pak and our customers around the world.”
Filtration Engineering, which will remain at its current location in Champlin, Minnesota, will become a unit of Tetra Pak Cheese and Powder Systems Inc. The existing Filtration Engineering sales channels outside the US will be maintained in a number of markets. The Filtration Engineering business will have further global coverage through Tetra Pak’s own marketing operations. For further information, visit www.tetrapak.com and www.filtrationeng.com
Toray extends Californian base
T
oray Membrane USA Inc (TMUS) has bought a building next to its existing manufacturing facility in Poway, California for sales and storage. The 15 000 sq ft building will be used as a finished goods warehouse for membrane bioreactor (MBR), hollow fine fibre and dairy/food/beverage spiral reverse osmosis (RO) and ultrafiltration (UF) membrane elements. The new building also includes offices for the TMUS sales, marketing, customer service, applications engineering and technical service departments. TMUS now owns all three buildings on the Californian campus.
For further information, visit www.toraywater.com
Exchange Rates against the US Dollar Date: 24.1.2013 Country Australia
Rate A$0.96
Country Netherlands
Austria
E0.75
Norway
Belgium
E0.75
Philippines
C$1.00
Singapore
Canada
Rate E0.75 NOK5.52 Peso40.71 S$1.23
China
CNY6.23
South Africa
R9.00
Denmark
DKK5.55
South Korea
KWn1074.79
Finland
E0.75
Spain
France
E0.75
Sweden
SEK6.47
Germany
E0.75
Switzerland
CHF0.93
Taiwan
T$29.17
Thailand
Bt29.89
India Italy
Rs53.76 E0.75
Japan
¥89.61
UK
Malaysia
Rt3.05
USA
16
Filtration Industry Analyst
E0.75
£0.63
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Fax: +44 (0) 1865 843973 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Publisher: David Hopwood Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Prices: 1291 for all European countries & Iran US$1448 for all countries except Europe and Japan ¥171 700 for Japan (Prices valid until 31 December 2013) To subscribe send payment to the address above. Tel: +44 (0)1865 843687 or via www.filtrationindustryanalyst.com Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 12976
US$1.00
January 2013